stars 1 stars 2 stars 3

SYnAbs' mission is to generate innovative antibodies against poor immunogenic compounds (steroids, small molecules, carbohydrates, epigenetic modifications) and complex antigens (GPCR, ion channels, toxins, transporters, proteins from viral envelopes) thanks to unique technologies (DNA immunization, syngeneic cell immunization, rat-LOU species). Anti-drug antibodies, surrogates, or therapeutics mAbs one-stop-shop solution from antigen to gr manufacturing.

SYnAbs Questions

The SYnAbs annual revenue was $11 million in 2026.

Julien Isoard is the Chairman and CEO of SYnAbs.

8 people are employed at SYnAbs.

SYnAbs is based in Charleroi, Walloon Region.

The NAICS codes for SYnAbs are [5417, 541, 541713, 54, 54171].

The SIC codes for SYnAbs are [87, 873].

Top SYnAbs Employees

View Similar People
Learn More
How It Works
get free account
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups.
search page
Search the #1 Contact Database
Get contact details of over 700M profiles across 60M companies – all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
get contact page
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.
G2 Leader Winter 2026 G2 Leader Mid Market Winter 2026 G2 Leader Small Business Winter 2026 G2 Most Implementable Winter 2026 G2 Best Est ROI Mid Market Winter 2026 G2 Leader Momentum Winter 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2025
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users